Drug Discovery Management
BC-1500
Level 1
Pharmaceuticals & Life Sciences
7 providers
16 API surfaces
3 rated strong or better
Target identification, hit-to-lead, lead optimisation.
Drug Discovery Management (BC-1500) is a level-1 business capability in the Pharmaceuticals & Life Sciences model. The catalog holds 16 API surface(s) from 7 provider(s) that can perform some part of it, 3 of them rated strong or better. Reach is the vendor surface that lands on this capability — it is not a claim about what any particular organisation has deployed.
Where this capability definition comes from.
This capability is part of a published business-architecture model that API Evangelist
did not author. It is redistributed here under
CC-BY-4.0.
Turbo EA Capabilities by Vincent Verdet — Turbo EA, https://github.com/vincentmakes/turbo-ea-capabilities, CC BY 4.0
Changes: Consolidated from 333 per-L1 YAML files into one JSON; English only (upstream i18n/ omitted); descriptions whitespace-normalised. No capability was added, removed, renamed or re-parented.
Source repository · NOTICE and third-party framework attributions
Sub-capabilities
Target Identification & Validation Management BC-1500.10
Disease biology, target identification, target validation.
no catalog coverage
Hit Discovery Management BC-1500.20
High-throughput screening, virtual screening, hit identification.
no catalog coverage
Medicinal chemistry, SAR, lead optimisation.
1 provider,
1 API surface
Pre-Clinical Candidate Selection Management BC-1500.40
Candidate selection, IND-enabling studies.
no catalog coverage
Translational Research Management BC-1500.50
Translational science, biomarker development.
no catalog coverage
Compound libraries, samples, repository management.
3 providers,
10 API surfaces
Providers that reach this capability
Ordered by rating band. Reach means a provider publishes an API surface that can perform
some part of this capability — it is not a claim that any particular
organisation has deployed it.
Exemplar
1
Complete, well-documented, and agent-ready
Strong
2
Solid coverage with minor gaps
Developing
2
Usable, with meaningful gaps to close
Thin
1
Limited public surface area
Emerging
1
Early or largely undocumented
This page carries no rating. Capabilities are not rated. A capability is a description of what a business does, not a thing a company publishes, so a Kin Score would have nothing to measure.
The edge table is a Pro feature.
This page shows
which providers and tags reach Drug Discovery Management. The underlying
tag → capability edges — each with the quoted fragment of the provider's own
OpenAPI that evidences it, a calibrated confidence score, and the contract-provenance gate
it passed — are available through the API, along with company-level capability maps.
Only edges at confidence ≥ 0.7 with evidence found verbatim in
the source contract are published at all.
See plans →
·
How the edges are graded →